BC Innovations | Mar 25, 2019
Distillery Therapeutics

AbbVie's oral macrolide ABBV-4083 for lymphatic filariasis and onchocerciasis

DISEASE CATEGORY: Infectious disease INDICATION: Infectious Cell culture, mouse and gerbil studies identified an oral macrolide antibiotic that could help treat lymphatic filariasis and onchocerciasis, which are caused by Brugia malayi , Litomosoides sigmodontis , Onchocerca ochengi...
Items per page:
1 - 1 of 1